BOC Sciences delivers precision peptide synthesis services extended to complex chemical modifications, enabling researchers to obtain sequence-defined peptides bearing functional groups, labels, constrained architectures, and non-natural residues. Our integrated platform connects solid-phase assembly, orthogonal protection chemistry, site-selective modification, preparative purification, and multi-method characterization to support drug discovery, probe development, and materials research.
Modified peptide synthesis introduces defined chemical groups, noncanonical residues, structural constraints, labels, lipids, polymers, glycans, or other functional components into a peptide sequence. Modifications may be installed at the N-terminus, C-terminus, amino acid side chains, peptide backbone, or multiple selected positions. Modified peptides are essential tools for studying protein-protein interactions, optimizing pharmacokinetic properties, developing diagnostic reagents, and engineering biomaterials with defined biological responses.
We install functional groups, blocking moieties, and affinity handles at the N-terminus to alter stability, charge, detection capability, and conjugation potential.
C-terminal modifications adjust charge state, introduce functional handles, and create peptide amides or acid derivatives for specific biological and chemical contexts.
BOC Sciences performs peptide bioconjugation chemistry on side chain residues to introduce functional groups at internal positions while preserving overall peptide architecture.
We construct conformationally constrained cyclic peptides that exhibit enhanced stability, improved target affinity, and greater membrane permeability compared to linear counterparts.
Backbone modifications alter the peptide backbone itself to modulate conformational flexibility, hydrogen bonding, protease susceptibility, and physicochemical properties.
We design and assemble peptides bearing multiple distinct modifications at predefined positions for advanced assay systems, bivalent ligands, and multifunctional constructs.
Share the sequence, modification sites, required functional groups, intended application, quantity, and analytical expectations. BOC Sciences will assess chemical compatibility and develop a project-specific synthesis, modification, purification, and characterization plan.
Modification selection depends on the peptide sequence, attachment site, intended function, chemical compatibility, and downstream analytical method. BOC Sciences supports individual and combined modification options, including:
| Modification Compound or Group | Representative Options | Supported Services and Research Uses |
| Polyethylene Glycol | Discrete PEGn, short-chain PEG spacers, linear PEG, branched PEG, and heterobifunctional PEG linkers. | PEGylation at terminal or side-chain positions, hydrophilicity adjustment, steric spacing, solubility improvement, conjugate construction, and peptide property studies. |
| Fluorophores | Fluorescein derivatives, rhodamine derivatives, cyanine-type dyes, coumarins, near-infrared dyes, and environment-sensitive probes. | Fluorescent dye labeling, single- or dual-label installation, spacer selection, free-dye removal, spectral testing, molecular imaging research, and fluorescence-based assays. |
| Biotin and Affinity Tags | Biotin, PEG-biotin, desthiobiotin, affinity handles, purification tags, and immobilization linkers. | Biotin labeling, N-terminal or lysine-directed attachment, affinity capture, pull-down studies, immobilization, binding assays, and detection reagent development. |
| Lipids and Fatty Acids | Palmitic acid, myristic acid, stearic acid, cholesterol derivatives, phospholipids, lipoic acid, and custom lipid anchors. | N-terminal or side-chain lipidation, linker design, hydrophobic peptide purification, membrane-association research, delivery-system development, and lipidated peptide characterization. |
| Glycans and Carbohydrates | Monosaccharides, oligosaccharides, amino sugars, glycosylated amino acids, and carbohydrate-derived ligands. | Site-defined glycopeptide synthesis, protected glycosylated building-block incorporation, glycan-peptide conjugation, recognition studies, and structure-function research. |
| Phosphate and Other PTM Groups | Phosphate, sulfate, methyl, acetyl, hydroxyl, ubiquitin-related motifs, and other post-translational modification mimics. | Phosphorylation, sulfation, methylation, acetylation, multisite PTM installation, enzyme-substrate studies, antibody preparation, and signaling research. |
| Stable Isotopes | 13C-, 15N-, and 2H-labeled amino acids, labeled terminal groups, and isotope-coded linkers. | Stable isotope labeling, internal standard preparation, quantitative mass spectrometry, metabolic research, structural analysis, and method development. |
| Chelators and Metal-Binding Groups | Macrocyclic chelators, acyclic chelators, metal-binding amino acids, histidine-rich motifs, and custom coordination ligands. | Site-selective chelator attachment, spacer optimization, metal-complex research, imaging-probe development, affinity studies, and analytical confirmation. |
| Reactive Handles and Linkers | Azides, alkynes, strained alkynes, tetrazines, trans-cyclooctenes, maleimides, thiols, aminooxy groups, and hydrazides. | Preparation of conjugation-ready peptides, click-compatible peptide intermediates, orthogonal dual-handle installation, surface immobilization, and multicomponent assembly. |
| Noncanonical Amino Acids | D-amino acids, N-methyl amino acids, beta-amino acids, constrained residues, fluorinated residues, and functional amino acid analogs. | Sequence-specificHydrophobic segments, repeated residues incorporation, backbone engineering, conformational control, proteolytic stability studies, structure-activity investigation, and peptidomimetic research. |
Share your target sequence, desired modification type and position, quantity, purity target, and intended application. Our specialists design a project-specific synthesis and modification plan covering route selection, protection strategy, assembly conditions, modification chemistry, purification, and analytical confirmation.
BOC Sciences reviews the peptide sequence, modification sites, functional groups, terminal requirements, expected quantity, intended research use, and analytical needs. Potential concerns such as hydrophobicity, aggregation, oxidation, steric hindrance, and incompatible modification chemistry are identified before the synthesis plan is confirmed.
Our chemists select SPPS, LPPS, fragment ligation, or a hybrid route and determine the resin, coupling reagents, protecting groups, modification order, cleavage conditions, and cyclization approach. Small-scale feasibility experiments and reaction condition optimization may be used for sensitive or competing transformations.
The peptide is assembled using sequence-appropriate coupling and deprotection conditions. Modifications are introduced on-resin, during fragment preparation, or after cleavage according to chemical compatibility. Reaction progress is monitored at critical steps, and sequential modifications are performed using orthogonal or chemoselective handles.
Crude material is purified using a method selected for the peptide's charge, hydrophobicity, molecular size, and modification pattern. Clients receive the final peptide with relevant analytical results, such as HPLC and mass spectrometric data, together with project-specific preparation and handling information.
Hydrophobic, repetitive, or beta-sheet-forming sequences often fail during standard SPPS due to incomplete coupling, on-resin aggregation, or poor solvation. BOC Sciences addresses these challenges by deploying pseudoproline dipeptides, Dmb-protected glycines, elevated temperature synthesis, PEG-based resins, and alternative solvents. For severely problematic sequences, we switch to fragment condensation or ligation approaches. Real-time UV monitoring and Kaiser testing at each cycle identify problem positions early, enabling mid-route optimization rather than complete restart.
Random labeling of lysine or cysteine residues produces heterogeneous product mixtures that complicate purification and obscure structure-activity relationships. BOC Sciences implements orthogonal protection strategies using Alloc, ivDde, Mmt, and acetamidomethyl groups to mask reactive side chains while exposing only the target site. For absolute site precision, we employ chemoselective ligation at N-terminal serine/cysteine, enzymatic modification, or incorporation of non-natural amino acids with unique reactivity. Method development for modification stoichiometry, reaction time, and buffer optimization ensures high conversion at the designated position.
Installing phosphorylation, PEGylation, acetylation, and fluorescent labels on a single peptide requires careful sequencing of deprotection, coupling, and purification steps to avoid cross-reactivity and side-product accumulation. BOC Sciences designs multi-step modification protocols with orthogonal protecting group combinations that release one functional group while maintaining protection on others. Each modification step is monitored by LC-MS before proceeding to the next, ensuring stepwise fidelity and enabling troubleshooting at intermediate stages rather than discovering failures at the final product.
Modified peptides often exhibit altered chromatographic behavior compared to their unmodified counterparts: hydrophobic labels cause strong column retention, acidic modifications broaden peaks, and bulky groups shift elution unpredictably. BOC Sciences screens multiple stationary phases (C4, C8, C18, phenyl-hexyl), mobile phase systems (TFA, formic acid, ammonium bicarbonate), and purification modes (reversed-phase, ion-exchange, size-exclusion) to identify optimal separation conditions. For particularly challenging separations, we employ two-dimensional purification or custom synthesis of reference standards for co-elution comparison.
Work with BOC Sciences to integrate sequence assessment, modification-site planning, orthogonal protection, peptide assembly, selective functionalization, purification, and analytical verification within one coordinated project.
BOC Sciences offers 200+ standard peptide modifications including terminal capping, side chain functionalization, cyclization, phosphorylation, lipidation, PEGylation, fluorescent labeling, biotinylation, and non-natural amino acid incorporation. Custom modification development is available for novel chemistries not in our standard catalog.
We do not apply generic protocols to every sequence. Our chemists analyze sequence hydrophobicity, aggregation propensity, modification chemistry requirements, and protecting group compatibility to design project-specific synthesis routes. This tailored approach reduces failed attempts and improves crude product quality for difficult sequences.
Modified peptide projects require tight feedback between synthesis and analytical verification. Our analytical platform provides same-day LC-MS and HPLC feedback during synthesis, enabling real-time route adjustment. Final products are delivered with comprehensive data packages including molecular weight confirmation, purity assessment, modification site verification, and batch-to-batch consistency data.
From milligram-scale exploratory synthesis to multi-gram preparation, from single modifications to complex multi-label constructs, BOC Sciences adapts project scope to research needs. We support customizable purity targets at multiple levels, deliver desalted or HPLC-purified material, and accommodate special formulation requests including lyophilization, specific buffer exchange, and concentration adjustment.
Client Needs: A signal transduction research group required a 23-amino-acid peptide bearing phosphorylated serine at position 8 and phosphorylated tyrosine at position 15 for studying dual-phosphorylation-dependent protein recruitment. The sequence contained three additional serines and two tyrosines that must remain unphosphorylated.
Challenges: Global phosphorylation would produce an inseparable mixture of phosphorylated isoforms. The phosphoamino acids introduced additional negative charges that reduced solvation during SPPS, and the target peptide showed strong tendency to form intra-chain hydrogen bonds.
Solution: We selected ivDde for lysine protection and Trt for unmodified serine/tyrosine side chains, leaving only Ser-8 and Tyr-15 exposed. The peptide was assembled on Rink amide resin using pseudoproline dipeptides at positions 10-11 and 18-19 to disrupt aggregation. Phosphorylation was performed on-resin using phosphoramidite chemistry with tetrazole activation. The crude product was analyzed by LC-MS/MS to confirm modification sites, then purified by preparative RP-HPLC with a shallow acetonitrile gradient.
Outcome: The client received 85 mg of >95% pure dual-phosphorylated peptide with confirmed site-specific modification, enabling successful pull-down experiments and subsequent crystallography studies.
Client Needs: A membrane biology team needed a cell-penetrating peptide dual-labeled with a palmitoyl chain at the N-terminus and Cy5 at the C-terminus for tracking membrane insertion and intracellular distribution by confocal microscopy. The peptide contained two lysines and one cysteine that must remain unmodified.
Challenges: The palmitoyl chain made the N-terminus extremely hydrophobic, causing precipitation during C-terminal Cy5 attachment. The cysteine thiol was prone to oxidation and unwanted side reactions, and the dual hydrophobic/hydrophilic character produced broad, poorly resolved HPLC peaks.
Solution: We synthesized the peptide on Rink amide resin with Acm protection on cysteine and ivDde on lysines. The N-terminal palmitoyl group was installed via palmitic acid NHS ester after selective N-terminal deprotection. Following cleavage, the C-terminal amide was converted to a free acid, activated, and coupled to Cy5-amine. Cysteine deprotection and oxidation to the desired disulfide dimer were performed in the final step. Purification was optimized on a C4 column with 0.1% TFA/gradient acetonitrile containing 10% isopropanol to improve peak shape.
Outcome: The team obtained 45 mg of >92% pure dual-labeled lipidated peptide suitable for microscopy imaging, with confirmed palmitoyl and Cy5 incorporation by LC-MS and UV-Vis spectroscopy.
BOC Sciences supports N-terminal, C-terminal, side-chain, backbone, cyclic, and multisite peptide modifications. Available options include acetylation, amidation, phosphorylation, methylation, sulfation, glycosylation, PEGylation, lipidation, biotinylation, stable isotope labeling, fluorescent labeling, reactive-handle installation, and noncanonical amino acid incorporation. Multiple modification types may also be combined when their protecting groups and reaction conditions are chemically compatible. The final modification scheme is selected according to the sequence, attachment position, intended function, purification behavior, and analytical requirements.
Modification-site control begins with an assessment of every potentially reactive residue in the peptide sequence. BOC Sciences may use orthogonal protecting groups, selectively addressable amino acid building blocks, terminal-selective reactions, chemoselective ligation, or bioorthogonal handles to expose only the intended attachment site. For peptides containing multiple lysines, cysteines, hydroxyl groups, or carboxyl groups, the modification order is planned to minimize positional isomers and cross-reactivity. LC-MS/MS or peptide mapping can be included when molecular mass alone cannot distinguish different modification sites.
Yes. BOC Sciences can design peptides containing two or more defined modifications, such as multisite phosphorylation, fluorophore-biotin combinations, lipid-label combinations, PEGylation with an affinity handle, or multiple reactive groups. These projects require a sequential route in which protecting groups, deprotection conditions, cleavage chemistry, and modification reactions remain mutually compatible. Intermediate HPLC and mass spectrometric analysis may be performed after critical steps to confirm successful installation before the next modification is introduced, reducing the risk of discovering an incompatibility only after final synthesis.
Difficult sequences are evaluated for hydrophobicity, charge distribution, aggregation tendency, secondary-structure formation, oxidation sensitivity, and modification-related steric effects. Depending on the identified risk, BOC Sciences may adjust resin loading, solvent composition, coupling cycles, reaction temperature, protecting-group strategy, or cleavage conditions. Pseudoproline-assisted assembly, backbone protection, fragment condensation, hybrid SPPS-LPPS synthesis, or chemoselective ligation may be considered for challenging targets. Purification conditions are also adapted because lipids, fluorophores, glycans, and PEG groups can substantially change peptide solubility and chromatographic retention.
A feasibility assessment normally requires the complete peptide sequence, exact modification type, intended attachment position, terminal configuration, disulfide or cyclization pattern, required quantity, and intended research application. Researchers should also identify any preferred linker, label, isotope, lipid, PEG unit, glycan, or noncanonical residue. Information about acceptable counterions, solubility concerns, downstream buffers, and required analytical methods is helpful. BOC Sciences uses these details to evaluate chemical compatibility, select the synthesis route, plan orthogonal protection, anticipate purification challenges, and propose an appropriate characterization package.
BOC Sciences helped us compare several modification positions and linker designs instead of applying a single standard approach. Their team developed a practical route that accommodated both the structural constraint and the functional label required for our peptide study.
— Armstrong, Senior Scientist, Peptide Research
The analytical package clearly connected the chromatographic profile with the mass spectrometric results and modification-site assessment. This made it easier for our project team to understand the major peptide species and select the material for downstream experiments.
— Spencer, Research Project Manager
Communication remained clear throughout route assessment, synthesis, modification, and purification. The team responded quickly when we adjusted the labeling position and explained how the change would affect protecting-group selection, analytical testing, and the overall project plan.
— Romano, Scientist, Molecular Assay Development
Our sequence had previously shown poor assembly and difficult purification behavior. BOC Sciences evaluated the likely aggregation points, adjusted the synthesis strategy, and used orthogonal analytical methods to distinguish the desired modified peptide from closely related impurities.
— Bergman, Research Lead, Biomolecular Engineering
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
